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ABSTRACT
Human cells can sense mechanical stress acting upon integrin
adhesions and respond by sending the YAP (also known as YAP1)
and TAZ (also known as WWTR1) transcriptional co-activators to
the nucleus to drive TEAD-dependent transcription of target genes.
How integrin signaling activates YAP remains unclear. Here, we show
that integrin-mediated mechanotransduction requires the Enigma
and Enigma-like proteins (PDLIM7 and PDLIM5, respectively;
denoted for the family of PDZ and LIM domain-containing proteins).
YAP binds to PDLIM5 and PDLIM7 (hereafter PDLIM5/7) via its
C-terminal PDZ-binding motif (PBM), which is essential for full
nuclear localization and activity of YAP. Accordingly, silencing of
PDLIM5/7 expression reduces YAP nuclear localization, tyrosine
phosphorylation and transcriptional activity. The PDLIM5/7 proteins
are recruited from the cytoplasm to integrin adhesions and F-actin
stress fibers in response to force by binding directly to the key
stress fiber component α-actinin. Thus, forces acting on integrins
recruit Enigma family proteins to trigger YAP activation during
mechanotransduction.
This article has an associated First Person interview with the first
author of the paper.
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INTRODUCTION
Integrin adhesion to the extracellular matrix is a fundamental
mechanism controlling tissue growth and form during normal
development (Wickstrom et al., 2011) and in cancer (Hamidi et al.,
2016). In addition to providing adhesion to the matrix, integrins
enable cells to sense mechanical forces to activate ‘inside-out
signaling’, which stimulates integrin binding to matrix ligands,
as well as ‘outside-in signaling’, which activates cytoplasmic
mechanotransduction pathways to regulate cell behavior (Legate
et al., 2009; Ross et al., 2013; Sun et al., 2016). In particular, focal
adhesion kinase (FAK; also known as PTK2) and Src family kinases
have important roles in integrin signaling (Avizienyte and Frame,
2005) and in synergy between integrin and growth factor signaling
(Chen et al., 2018). Recent work has unveiled a consensus integrin
adhesome containing a large number of proteins that are likely to be
involved in either adhesion or mechanotransduction (Horton
et al., 2015).
One crucial downstream effector of integrin signaling is the
Yes-associated protein (YAP, also known as YAP1), originally
discovered by virtue of its ability to form a complex with the Src
family kinase, Yes (Sudol, 1994). YAP (and its paralog TAZ, also
known as WWTR1) was found to be a transcriptional co-activator
that is negatively regulated by interaction with 14-3-3 proteins (after
serine phosphorylation) and positively regulated by interaction with
PDZ domains (via a C-terminal PDZ-binding motif or PBM) (Kanai
et al., 2000; Yagi et al., 1999). YAP was subsequently shown to
function as a co-activator for the TEAD family of DNA-binding
transcription factors, even though the majority of the YAP protein
was localized to the cytoplasm in complex with 14-3-3 proteins
(Vassilev et al., 2001). Although YAP is cytoplasmic at high cell
density, it can translocate to the nucleus when cells lose contact with
one another and/or spread out across their substrate (Zhao et al.,
2007). Importantly, the nuclear localization of YAP was shown to
require the presence of the C-terminal PDZ-binding motif (Oka and
Sudol, 2009). YAP shuttles dynamically between the cytoplasm and
nucleus, with its bulk distribution likely to be determined by relative
binding to cytoplasmic (e.g. 14-3-3) versus nuclear (e.g. TEAD)
proteins (Badouel et al., 2009; Ren et al., 2010; Vassilev et al., 2001;
Zhang et al., 2008; Zhao et al., 2007), or possibly through regulated
nuclear import or export (Ege et al., 2018; Furukawa et al., 2017;
Manning et al., 2018).
Culture of cells on micropatterns and different matrix types
suggested that the size of the contact cells make upon spreading over
their basal substrate, substrate stiffness and the resulting mechanical
tension on F-actin stress fibers are key determinants of YAP
subcellular localization in response to cell density (Dupont et al.,
2011; Wada et al., 2011). Nevertheless, different groups have drawn
opposite conclusions as to whether mechanical tension on stress
fibers signals via the Hippo pathway kinases LATS1 and LATS2
(hereafter LATS1/2) to control YAP localization, or via a LATS1/2-
independent pathway (Dupont et al., 2011; Meng et al., 2018; Wada
et al., 2011). Recent work has confirmed a key role for integrin
adhesion to the extracellular matrix and integrin signaling via talin,
Rho and Src family kinases as important mechanosensory
mechanisms that regulate YAP (Elbediwy et al., 2016; Elosegui-
Artola et al., 2016; Kim and Gumbiner, 2015; Tang et al., 2013).
Integrin–Src signaling can affect LATS1/2-mediated phosphorylation
of YAP (Elbediwy et al., 2016; Kim and Gumbiner, 2015) possibly
via direct tyrosine phosphorylation of LATS1 (Si et al., 2017), or via
crosstalk with growth factor signaling (Fan et al., 2013; Kim and
Gumbiner, 2015). Alternatively, integrin–Src signaling can also
activate YAP via direct tyrosine phosphorylation of YAP in its
transcriptional activation domain (Li et al., 2016; Taniguchi et al.,
2015). Finally, YAP can also sense mechanical stretching of
E-cadherin-based adherens junctions (Benham-Pyle et al., 2015),
possibly via Ajuba, LIMD1 and TRIP6-mediated LATS1/2Received 20 June 2018; Accepted 16 October 2018
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inhibition (Dutta et al., 2018; Ibar et al., 2018; Rauskolb et al.,
2014), via Hippo kinase (MST1 and MST2) inactivation (Fletcher
et al., 2018), or via Src activation at adherens junctions (Gomez
et al., 2015; Kim et al., 2011; McLachlan et al., 2007; Roura et al.,
1999; Serrels et al., 2011; Shindo et al., 2008; Tsukita et al., 1991).
How YAP might be recruited to integrin (or E-cadherin) adhesions
in order to be directly phosphorylated by Src family kinases in
response to mechanical force is an important unsolved problem.
RESULTS AND DISCUSSION
To identify possible binding partners of YAP, we performed
immunoprecipitation (IP) and mass spectrometry (IP-MS) of GFP-
tagged human YAP transfected into human HEK293T cells. Aside
from many known interactors, which confirm the quality of our
IP-MS analysis, we identified novel interactors including the PDZ
and LIM domain-containing (PDLIM) family proteins Enigma
(PDLIM7) and Enigma-like (PDLIM5) (Fig. 1A–C). Note that both
Enigma family proteins were identified as members of the integrin
adhesome, although their function remains poorly understood
(Horton et al., 2015). We confirmed this interaction by co-IP of
GFP–YAP and western blotting for the Enigma family proteins
PDLIM5 and PDLIM7 (hereafter PDLIM5/7) (Fig. 2A).
Importantly, deletion of the YAP PBM motif (YAPΔC) abolished
the interaction between YAP and PDLIM5/7, suggesting that
PDLIM5/7 bind to YAP via the PBM motif (Fig. 2A). We further
find that IP of endogenous YAP also pulls down endogenous
PDLIM5/7 (Fig. 2B). We confirmed previous observations (Oka
and Sudol, 2009; Shimomura et al., 2014) that the PBM motif is
important to promote YAP nuclear localization by comparison of
the localization of transfected GFP–YAP with GFP–YAPΔC in
sparsely plated human Caco2 epithelial cells (Fig. 2C,D).
To test whether Enigma family proteins are required for YAP to
localize to the nucleus upon cellular stretching, we plated human
Caco2 cells at a moderate density, and transfected them with either
control or PDLIM5/7-targeted siRNAs. We find that control
siRNAs had no effect, while silencing of the Enigma family
proteins strongly inhibited nuclear localization of YAP, without
affecting cell shape or density (Fig. 2E–G). Silencing of PDLIM5/7
also reduced the Src family kinase-dependent phosphorylation
of YAP on Y375 and Y428, similar to what is seen upon loss of
the YAP C-terminal PBM, without affecting the levels of
phosphorylated Src (p-Src) or its localization to focal adhesions
(Fig. 2H,I; Fig. S1). The reduction in YAP transcriptional activity
upon siRNA knockdown of PDLIM5/7 was also comparable to that
seen upon deleting the YAP C-terminal PBM in a TEAD-multimer
reporter gene assay (Fig. 2J). Analysis of the YAP target genes
AREG, MYC and PCNA by quantitative PCR (qPCR) revealed a
comparable reduction in target gene expression upon silencing of
PDLIM5/7 (Fig. 2K). Furthermore, the rate of cell proliferation, as
measured from a pulse of EdU incorporation in cells undergoing
S-phase of the cell cycle, is reduced upon silencing of
PDLIM5/7 (Fig. 2L). We conclude that Enigma family proteins
bind directly to YAP via the C-terminal PBM to promote YAP
tyrosine phosphorylation, nuclear localization and transcriptional
activation in human cells.
We next examined the subcellular localization of PDLIM7 and
PDLIM5. We find that both proteins localize to the cytoplasm in
densely cultured cells, similar to what is seen for YAP (Fig. 3A,B).
In response to spreading of the cells upon plating at low density,
both Enigma family proteins relocalize in part to F-actin stress fibers
and focal adhesions, as well as to F-actin fibers at adherens junctions
(Fig. 3A,B). At the same time, YAP translocates to the nucleus,
Fig. 1. YAP immunoprecipitation and mass-spectrometry analysis
of binding partners. (A) YAP IP-MS analysis of co-precipitated proteins
identifies the Engima family proteins PDLIM5 and PDLIM7 as novel YAP-
associated proteins. Axes are log10-transformed values. (B) List of all YAP-
associated proteins identified in the experiment shown in A. (C) Comparison
of confidence ratios for PDLIM5/7 and known YAP interactors.
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suggesting that the relocalization of Enigma proteins to sites of
mechanical force sensing could be a trigger for YAP nuclear
localization (Fig. 3A,B). Accordingly, PDLIM5/7 can both be
detected in a complex with the F-actin stress fiber component
α-actinin 1 (ACTN1; Fig. 3C,D).We propose that, upon mechanical
stimulation of human cells, Enigma family proteins bind to
α-actinin 1 on F-actin stress fibers at integrin focal adhesions in
order to promote tyrosine phosphorylation of YAP by Src family
kinases, and thus YAP activation (Fig. 3D). Note that we find
similar co-regulation of YAP and Enigma when cells are
Fig. 2. See next page for legend.
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mechanically stimulated by plating on matrices of varying stiffness
(Fig. S2). Interestingly, Src family kinases can also be activated at
α-actinin-containing F-actin cables organized by E-cadherin-
containing adherens junctions (McLachlan et al., 2007), and we
are also able to detect some PDLIM5/7 localization with p-Src at
adherens junctions as well as at focal adhesions (Fig. S3).
We sought to test our hypothesis that Enigma proteins can induce
nuclear localization of YAP by promoting direct phosphorylation of
YAP by Src family kinases, rather than through an indirect
mechanism that requires the phosphorylation of YAP by LATS
family kinases. To test this idea, we examined the localization of
phosphorylation mutant YAP5SA (with the five serine residues in
YAP mutated in alanine residues), which is unable to be inhibited
by canonical Hippo–LATS1/2 kinase signaling. We find that human
YAP5SA remained cytoplasmic in densely cultured cells and
became nuclear in sparsely cultured cells, indicating the
requirement for a parallel pathway that regulates YAP nucleo-
cytoplasmic translocation independently of canonical Hippo
signaling (Fig. 4A). Treatment with the Src family kinase
inhibitor Dasatinib, or PDLIM5/7 siRNA, reduced nuclear
localization of YAP5SA, such that most cells had a comparable
level of YAP5SA in both nucleus and cytoplasm – similar to the
effect of Src/Fyn/Yes triple siRNA on endogenous YAP
localization (Fig. 4A–C; Fig. S1). We next considered whether
direct phosphorylation of YAP on multiple tyrosine residues by Src
family kinases (Li et al., 2016) could account for density-dependent
regulation of YAP5SA (Fig. 4D). Accordingly, we find that
mutation of three tyrosine residues to phenylalanine (3YF) in the
YAP transcriptional activation domain (TAD) reduces the nuclear
localization of YAP5SA, similar to what was seen upon treatment
with Dasatinib (Fig. 4D–F). Finally, Dasatinib also reduced YAP
nuclear localization even in the absence of LATS1/2 induced by
either siRNA silencing in densely cultured human epithelial cells
(Fig. 4G–I) or by double-conditional knockout of homozygous
floxed LATS1fl/fl and LATS2fl/fl upon ubiquitous expression of
tamoxifen-inducible Cre-ERt allele together with GFP–YAP in
mouse embryonic fibroblasts (Fig. 4J,K). These results suggest
parallel regulation of YAP by LATS1/2 and Src family kinases in
response to cell density, in agreement with recent findings in
cholangiocarcinoma cells (Sugihara et al., 2018). Interestingly, we
find overexpression of PDLIM proteins results in a moderate
reduction in YAP localization (Fig. S4). This is consistent with the
idea that PDLIM proteins act as a bridge between YAP and integrin
adhesions, as overexpression would be predicted to saturate YAP in
the cytoplasm and prevent productive association with integrin
adhesions, thus reducing YAP tyrosine phosphorylation and nuclear
localization.
In conclusion, our results indicate that mechanical stress-induced
binding of Enigma proteins to α-actinin to basal stress fibers
provides a platform for YAP to be tyrosine phosphorylated by Src
family kinases to promote YAP nuclear localization and the full
activation of YAP-driven transcription. Further work is necessary to
understand how tyrosine phosphorylation promotes YAP
localization to the nucleus, although such phosphorylation could
promote either nuclear import, as in the case of STAT proteins
(Reich, 2013; Reich and Liu, 2006), or interaction with nuclear
proteins, such as TEADs or SWI/SNF components, which could
maintain nuclear localization as well as regulate transcription
(Skibinski et al., 2014; Song et al., 2017; Zhu et al., 2015).
Importantly, this Enigma-dependent mechanism for regulation of
YAP must act in parallel to inhibition of the canonical Hippo
pathway initiated by integrin signaling, via multiple signaling
pathways (Elbediwy et al., 2016; Elosegui-Artola et al., 2016; Kim
and Gumbiner, 2015; Kissil et al., 2002; Meng et al., 2018; Sabra
et al., 2017; Si et al., 2017; Xiao et al., 2002). It must also act in
parallel to any direct mechanical regulation of the nucleus, which
becomes strongly deformed and permeable to small proteins in
extremely flattened cells (Elosegui-Artola et al., 2017; Shiu et al.,
2018) and, indeed, Enigma proteins are no longer required for
nuclear localization of YAP upon such extreme cellular
flattening (data not shown). In future, it will be of great interest to
investigate with genetically modified mice which of these
mechanotransduction pathways operates in different mammalian
tissues in vivo.
MATERIALS AND METHODS
Plasmids
pEGFP C3-YAP2 and pEGFP C3-YAP-DeltaC plasmids were Addgene
plasmids #19055 and #21126 (deposited by Marius Sudol). pCMV-Flag
YAP2 5SAwas Addgene plasmid #27371 (deposited by Kun-Liang Guan).
pEGFP C3-YAP2 3YF and pCMV-Flag YAP2 5SA 3YFwere created using
pEGFP C3-YAP2 and pCMV-Flag YAP2 5SA, respectively, by mutating
the three tyrosine residues in question (Y375F Y391F and Y428F). Note the
YAP constructs are generated using mRNA isoform 3. Site directed
mutagenesis was performed by Creative Biogene. pEGFP-N1 α-actinin 1
was Addgene plasmid #11908 (deposited by Carol Otey). pNL2.2 -
8×TEAD and pRL-CMV Renilla were from Promega. All plasmids were
transfected using Lipofectamine 3000 (Invitrogen). To constitutively
overexpress human PDLIM7, the PDLIM7 (isoform 1) open-reading
frame (ORF) was subcloned from the corresponding entry vector
(Dharmacon; clone 3562 for PDLIM7 isoform 1) into the destination
vector pcDNA-PDEST47 (Invitrogen, 12281010) by recombination using
the Gateway LR clonase enzyme mix (Invitrogen,11791).
Fig. 2. The Enigma family proteins PDLIM5/7 bind to the YAP C-terminal
PBM and promote YAP nuclear localization and transcriptional activity.
(A) Confirmation of YAP–PDLIM5 and YAP–PDLIM7 interaction by co-
immunoprecipitation (IP) of GFP-tagged YAP, and immunoblotting with anti-
PDLIM5 and anti-PDLIM7 antibodies. Both Enigma family proteins PDLIM5
and PDLIM7 bind to the YAP C-terminal PBM, as deletion of this motif
(YAPΔC) abolishes the interaction in co-immunoprecipitation experiments.
(B) Endogenous YAP co-immunoprecipitates with PDLIM5 and PDLIM7.
(C) Deletion of the C-terminal PBM (YAPΔC) reduces nuclear localization of
GFP-tagged YAP in human Caco2 cells plated at low density. Results in A–C
are representative of n=3 biological replicates. (D) Quantification (mean±s.d.,
n=3) of YAP localization for experiments as shown in C. ****P<0.001
(Student’s t-test). (E) Double-silencing of both PDLIM5 and PDLIM7
expression in human Caco2 cells strongly reduces nuclear localization of YAP.
Results are representative of n=6 biological replicates. (F) Quantification
(mean±s.e.m.) of YAP localization for experiments as shown in E. ****P<0.001
(Student’s t-test). (G) Confirmation of depletion of PDLIM5 and PDLIM7
expression levels for the siRNA (si5/7) treatment used in E. C, control siRNA.
Results are representative of n=3 biological replicates. (H) Schematic diagram
of the interaction between the YAP PBM and the PDZ domain of PDLIM5/7
proteins. Proximity of Src phosphorylation sites to the PBM is shown.
(I) Silencing of PDLIM5/7 in human Caco2 cells reduces tyrosine
phosphorylation of YAP. Results are representative of n=3 biological
replicates. (J) Silencing of PDLIM5/7 in human Caco2 cells reduces YAP-
driven TEAD transcriptional activity, as measured by a TEAD multimer
luciferase reporter assay (relative to aRenilla luciferase control) (mean±s.e.m.,
n=10 from two independent experiments). Similar results were obtained
upon deletion of the YAP C-terminal PBM. ****P<0.001 (Student’s t-test).
(K) Silencing of PDLIM5/7 in human Caco2 cells reduces expression of the
YAP-target genes AREG, MYC and PCNA (mean±s.e.m., n=3). **P<0.01,
***P<0.005 (Student’s t-test). (L) Silencing of PDLIM5/7 in human Caco2 cells
reduces the rate of cell proliferation, as measured through a pulse of EdU
incorporation. Upon loss of PDLIM5/7, proliferation slows by approximately half
compared with control cells, which is comparable inmagnitude to that achieved
by silencing of YAP itself (siYAP). Results in the graph are mean±s.d. (n=3).
****P<0.001, ***P<0.005 (Student’s t-test). Scale bars: 20 µm (C,E,L).
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Human cell culture
Human Caco-2 cells and HEK293T (Francis Crick Institute cell services)
were grown in conditions as previously described (Elbediwy et al., 2016).
All cells were subject to mycoplasma testing.
Generation of LATS1/2 MEFs
All experiments were carried out in accordance with the United Kingdom
Animal Scientific Procedures Act (1986) and UK Home Office regulations
under project license number 70/7926. Mouse embryonic fibroblasts were
derived fromE14.5Lats1lox/lox;Lats2lox/lox (Yi et al., 2016)carrying theRosa26-
cre-ERT2 (Seibler et al., 2003) allele on amixed background.At passage 4 or 5,
100,000 cells were plated in each well of an eight-well Ibidi chamber slide. At
24 h after plating, pEGFPC3-YAP2was transfectedusingLipofectamine3000
while simultaneously adding tamoxifen. Transfectionwas left for a further 48 h
and the medium was changed 24 h post tamoxifen treatment before cells were
fixed and examined via a standard immunofluorescence protocol.
Fig. 3. PDLIM5/7 proteins localize in the cytoplasm in
dense cells but to basal stress fibers in sparse
cells and bind directly to the stress fiber component
α-actinin 1. (A) PDLIM5 localizes to the cytoplasm in
dense cells but translocates, in part, to F-actin stress
fibers and adherens junctions in sparsely plated cells.
(B) PDLIM7 localizes to the cytoplasm in dense cells
but translocates in part to F-actin stress fibers and
adherens junctions in sparsely plated cells. (C) Co-
immunoprecipitation of PDLIM5/7 proteins with GFP-
tagged α-actinin 1 from human Caco2 cells. Results
are representative of n=3 biological replicates.
(D) Schematic diagram of YAP recruitment via the
Enigma PDLIM5/7 proteins to integrin–Src signaling
complexes to sense mechanical forces basally. Scale
bar: 20 µm (A,B).
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Co-immunoprecipitation
HEK293T cells were transfected with the relevant plasmids using
Lipofectamine 2000. The sample was then lysed and subjected to co-
immunoprecipitation using a GFP Trap Kit containing lysis buffer
(10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% NP-40 and 0.5 mM
EDTA) (Chromotek). Lysis buffer was supplemented with PhosStop
Phosphatase Inhibitor Cocktail Tablets (Roche), Protease Inhibitor
Cocktail (Roche), 0.1 M NaF and 1 mM PMSF. Samples were left on
ice to solubilize for 10 min, before being centrifuged (10000 r.p.m. for
10 min at 4°C), pre-cleared and incubated with the GFP Trap-M beads
Fig. 4. See next page for legend.
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for 1 h. IPs were subjected to three washes before being lysed in 2×
sample buffer and boiled. For mass spectrometry, proteins were
subjected to SDS-PAGE followed by in-gel trypsin digestion. Peptide
mixtures were analyzed using a Q-Exactive mass spectrometer
connected to a U3000 nanoLC. Raw data was processed with
MaxQuant software using an estimated 1% false discovery rate for
protein identification and intensity-based absolute quantification (iBAQ)
for protein quantification. For endogenous IP, mouse anti-YAP antibody
(Santa Cruz Biotechnology, 63.7) was used at a concentration of 3 μg
and bound to Dynabeads. Caco-2 lysates were processed as for
overexpression co-IPs described above.
EdU incorporation assay
Cells were processed for RNAi as described above (siRNA transfection) and
processed with the Click-iT™ EdU Alexa Fluor™ 555 Imaging Kit
(Invitrogen) according to the manufacturer’s protocol.
qPCR
Extraction of total RNA from Caco-2 siRNA-transfected cells processed as
previously described (Elbediwy et al., 2016). Primers were purchased as
Quantitect Primers (Qiagen).
Antibodies
Antibodies used in mammalian cell culture were: mouse anti-GFP (clones
7.1 and 13.1, cat. no. 11814460001, Roche), mouse anti-Flag (M2, cat. no.
F1804, Sigma), rabbit anti-PDLIM5 (cat. no. HPA016740, Atlas
antibodies), rabbit anti-PDLIM7 (NBP1-84841, Novus), rabbit anti-YAP
H-125, mouse anti-YAP (63.7) (cat. nos sc-15407 and sc-101199, Santa
Cruz Biotechnology), mouse anti-α-actinin 1 (cat. no. ab18061, Abcam),
rabbit anti-pY418 Src (cat. no. 44-660G, Life Technologies) and rabbit anti-
Src (cat. no. 2108, Cell Signaling Technology) antibodies. Dilutions used
are available from the corresponding author upon request.
Fixation
Cells were fixed as previously described (Elbediwy et al., 2016) and were
lysed in 2× sample buffer (Tris-glycine SDS containing 1× sample reducing
agent; Novex).
Mechanotransduction
Cells were plated on Prime coat substrates (2 KPa, 10 KPa and 30 KPa)
(Excellness Biotech) and left for 24 h before being fixed and processed for
immunofluorescence.
siRNA transfection
siRNA transfection experiments were performed using Lipofectamine
RNAiMax (Invitrogen) in Optimem and antibiotic-free medium (Gibco).
Caco-2 and HEK293T cells were reverse transfected using a final
concentration of 80 nM siRNA. The following day, another round of
siRNA transfection was performed. Cells were left for a total of 72 h before
being either fixed in PFA for immunofluorescence or lysed in sample buffer
for immunoblotting. Oligonucleotides used for PDLIM5, PDLIM7, Src,
Fyn, Yes and YAP were as a siGenome pool (Dharmacon).
Inhibitor treatments
For Dasatinib experiments, cells were treated with 5 μM of the compound
(Selleck chemicals) for a period of 4 h.
Microscopy
Images were taken on a Leica SP5 laser-scanning confocal microscope.
Quantification
For YAP localization studies, quantification was scored as one of three
separate categories: N, nuclear; N/C, nuclear and cytoplasmic; and C,
cytoplasmic. Cells were assessed over three independent experiments
counting 500–600 cells per condition from random cellular areas. For
fluorescence intensity quantification, images were measured using six
independent areas of cells and over three independent experiments, and
processed using ImageJ. Graphs were plotted using Prism.
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Results are representative of n=3 biological replicates. (H) Quantification of
results from the experiment in G (n=3). (I) Confirmation that LATS1/2 siRNAs,
as used in experiment in G, effectively reduce LATS1 and LATS2 protein
levels. (J) LATS1/2 double floxed MEFs transfected with Cre-ERt and YAP
before treatment with Tamoxifen and Dasatinib to induce deletion of both
LATS1 and LATS2 genes. (K) Quantification of YAP nuclear localization in
experiments as in J (mean±s.e.m.; n=2 biological replicates each counting
at least 600 cells from 8–10 independent areas over many coverslips).
****P<0.001 (Student’s t-test). Scale bars: 20 μm (B), 30 μm (A,E), 50 μm (G,J).
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